” Eli Lilly said it will stop development of Enzastaurin experimental cancer drug after it failed in a late-stage trial to delay a worsening of symptoms in patients with lymphoma, but continues with late-stage trials of two other experimental cancer drugs. ”
Read Eli Lilly Lymphoma Drug, Enzastaurin, Fails In Late-Stage Trial HuffPost Healthy Living, 05/10/2013
All our posts tagged Eli Lilly – Big Pharma – Drugs